We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pharmacists Management of Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00869076
Recruitment Status : Completed
First Posted : March 25, 2009
Last Update Posted : March 25, 2009
Information provided by:

Study Description
Brief Summary:
The hypothesis is that patients with poorly controlled diabetes would have greater improvement in their blood sugar control when managed by a clinical pharmacist than when managed with usual medical care. Patients with poor control are randomized to pharmacist management or to usual medical care for one year.

Condition or disease Intervention/treatment Phase
Diabetes Mellitus Other: Pharmacist Management Other: Usual care Phase 4

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 102 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Pharmacist Management of Diabetes Mellitus: A Randomized Controlled Trial.
Study Start Date : May 2006
Primary Completion Date : December 2007
Study Completion Date : December 2007
Arms and Interventions

Arm Intervention/treatment
Experimental: Pharmacist Management
In this arm the Pharmacist managed the Diabetes in collaboration with the primary care physician
Other: Pharmacist Management
Pharmacist Managed the patient's diabetes in collaboration with their primary care physician
Active Comparator: Usual Care
The patient was managed by the primary care physician
Other: Usual care
Patient was managed by their primary care physician as usual

Outcome Measures

Primary Outcome Measures :
  1. Hgb A1c change [ Time Frame: 1 year ]

Secondary Outcome Measures :
  1. HgbA1c change based on ethnicity [ Time Frame: one year ]
  2. percent of patients with a 1 point or greater decrease in A1c [ Time Frame: one year ]
  3. Percent of patients with a 1 point decrease in A1c by ethnicity [ Time Frame: one year ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 18 years or older
  • A1c greater than or equal to 9.0

Exclusion Criteria:

  • Not expected to live for the duration of the study
  • Managed by an endocrinologist
  • Unwillingness to participate and attend pharmacist visits
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00869076

United States, Michigan
Advantage Health Physican Network
Grand Rapids, Michigan, United States, 49503
Sponsors and Collaborators
Advantage Health Physician Network
Doran Foundation
Michigan Pharmacist Foundation
Priority Health
Western Michigan Society of Health System Pharmacists
More Information

Responsible Party: John Jameson, PharmD., Ferris State University
ClinicalTrials.gov Identifier: NCT00869076     History of Changes
Other Study ID Numbers: PharmacistDiabetesJameson
First Posted: March 25, 2009    Key Record Dates
Last Update Posted: March 25, 2009
Last Verified: March 2009

Keywords provided by Advantage Health Physician Network:
Diabetes Mellitus

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases